Induction of puberty in Turner's syndrome
dc.creator | Menéndez, M. | |
dc.creator | Rumie, K. | |
dc.creator | García, H. | |
dc.date.accessioned | 2020-01-12T03:37:26Z | |
dc.date.available | 2020-01-12T03:37:26Z | |
dc.date.created | 2020-01-12T03:37:26Z | |
dc.date.issued | 2011 | |
dc.identifier | 10.4067/S0370-41062011000500009 | |
dc.identifier | 0370-4106 | |
dc.identifier | https://repositorio.uc.cl/handle/11534/27366 | |
dc.description.abstract | Turner's Syndrome is the most frequent cause of female hypogonadism. Puberty must be pharmacologically induced in over 80% of these girls. Induction must be completed in a manner closest to physiology as possible. It is recommended that this induction be initiated at age 12 y.o. with natural estrogens (17 beta estradiol) in low dosage, equivalent to 1/10 a 1/8 of substitution dose, increasing stepwise and adding, after two years, a progestin to generate a menstruation. This revision shows various proposed schemes, as well as therapeutic alternatives available in Chile. | |
dc.language | en | |
dc.subject | Hypogonadism | |
dc.subject | Puberty | |
dc.subject | Turner | |
dc.subject | Estradiol | |
dc.subject | Gestagen | |
dc.subject | Article | |
dc.subject | Hormone substitution | |
dc.subject | Human | |
dc.subject | Menstruation | |
dc.subject | Turner syndrome | |
dc.title | Induction of puberty in Turner's syndrome | |
dc.type | artículo |